Hematology News`Remarkable’: CAR T therapy for CLL/SLLJune 8, 2023CLLB Cell LymphomaNon-Hodgkin LymphomaCellular Therapy
Hematology NewsPMBCL: Postremission, patients may safely skip radiationJune 6, 2023B Cell LymphomaDLBCLNon-Hodgkin Lymphoma
Hematology NewsDLBCL: Major new treatment breakthroughsMay 17, 2023DLBCLMixed TopicsGene TherapyB Cell Lymphoma
Hematology NewsCLL: Venetoclax combos top first-line chemoimmunotherapyMay 12, 2023CLLB Cell Lymphoma
Oncology PracticeNumber of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Patient & Survivor CareLung CancerDiversity in MedicineBreast CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Hematology NewsCLL: Black patients die sooner than WhitesMay 8, 2023CLLDiversity in MedicineB Cell Lymphoma
Hematology NewsA 50-year-old White male presented with a 4- to 5-year history of progressively growing violaceous lesions on his left lower extremityApril 12, 2023B Cell Lymphoma
Hematology NewsB-cell cancers: Sparse insight into preventing infectionsMarch 28, 2023CLLB Cell LymphomaMixed Topics
Hematology NewsErythema extent predicts death in cutaneous GVHDMarch 13, 2023TransplantMixed TopicsMultiple MyelomaCLLB Cell LymphomaMantle Cell Lymphoma
Hematology NewsCLL treatment: More infections among real-world patientsMarch 6, 2023CLLB Cell Lymphoma
Hematology NewsFDA approves first-in-class drug for follicular lymphomaDecember 23, 2022B Cell LymphomaMixed Topics
Hematology NewsCAR T-cell therapy neurotoxicity linked to NfL elevationsOctober 3, 2022Cellular TherapyAggressive LymphomasALLB Cell LymphomaMultiple MyelomaMixed TopicsCLL
